• French Patent Litigators
  • The Firm
    • Know-how
    • Team
      • Matthieu DHENNE
      • Benjamin MOLLET-VIEVILLE
  • Fields of expertise
    • Patents
    • Employee Inventions
    • Contracts
    • Trade Secrets
    • Saisie-contrefaçon
    • Pharmaceutical regulations
    • UPC
  • Blog
  • Contact
  • French
  • French Patent Litigators
  • The Firm
    • Know-how
    • Team
      • Matthieu DHENNE
      • Benjamin MOLLET-VIEVILLE
  • Fields of expertise
    • Patents
    • Employee Inventions
    • Contracts
    • Trade Secrets
    • Saisie-contrefaçon
    • Pharmaceutical regulations
    • UPC
  • Blog
  • Contact
  • French

Moderna vs. Pfizer & BioNTech: French perspective

•Dhenne Avocats
•Uncategorized

The news was announced last week: Moderna is suing Pfizer for infringement of two of its patents related to Covid-19 vaccines. These highly targeted actions are likely to spread to many other countries: here is a brief overview of the case and its potential French perspective.

For more information: link.

Previous PostFrench Judge Competent for Infringement Abroad: Private International Law vs. UPC?Next PostOPPO’s New FRAND Order: “You got your injunction? Well, I quit” (French perspective)

Related Posts

Trastuzumab x recombinant human hyaluronidase: the French Supreme Court clarifies the interpretation of article 1 b) of the SPC Regulation

•21 February 2023•Dhenne Avocats

“Nivolumab and pembrolizumab cases”: the French Supreme Court clarifies the interpretation of Article 3 a) of the SPC Regulation

•13 February 2023•Dhenne Avocats

“Thales” and “Bull” decisions: the French Supreme Court and the patentability of computer-implemented inventions

•7 February 2023•Dhenne Avocats